Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug Safety Should Focus On “Maximizing Benefit,” Not Just “Minimizing Risk” – FDA’s Goodman

This article was originally published in The Pink Sheet Daily

Executive Summary

Agency’s acting chief scientist emphasizes need for communication “in the face of uncertainty” and rejects the “either/or” choice of personalized medicine versus comparative effectiveness.

You may also be interested in...



Conspicuous Consumption: TB Therapies Are A Priority At FDA

A June 3 advisory committee discussion of tuberculosis drug development offers a good early case study of how the Hamburg FDA may benefit some classes of drug development

Conspicuous Consumption: TB Therapies Are A Priority At FDA

A June 3 advisory committee discussion of tuberculosis drug development offers a good early case study of how the Hamburg FDA may benefit some classes of drug development

Comparative Research Needs New Approach To Answer Real-Life Questions

To get the most out of the new funding for research on the comparative effectiveness of health care products and services, research needs to go in new directions so that it can answer real-world questions, two former CMS officials said at a recent forum at the American Enterprise Institute

Related Content

Topics

UsernamePublicRestriction

Register

PS069317

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel